← Back to Search

SmileyScope VR Group for Overactive Bladder

N/A
Waitlist Available
Led By Raveen Syan, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients undergoing elective peripheral nerve evaluation studies for pelvic floor dysfunction
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one hour post-procedure
Awards & highlights

Study Summary

This trial tests if virtual reality headsets can reduce pain and anxiety in medical procedures.

Eligible Conditions
  • Overactive Bladder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-pne procedure), up to 1 hour (post-pne procedure)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-pne procedure), up to 1 hour (post-pne procedure) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change In Pain as Measured by Numeric Pain Scale
Change in Anxiety as Measured by State Trait Anxiety Inventory
Secondary outcome measures
Feasibility for the Utilization of the Smiley Scope VR Headset by Likert Scale
Satisfaction with Procedure as measured by Likert Scale

Trial Design

2Treatment groups
Experimental Treatment
Group I: SmileyScope VR GroupExperimental Treatment1 Intervention
Participants in this group will wear the SmileyScope VR set during the PNE procedure for approximately 40 minutes.
Group II: No VR GroupExperimental Treatment1 Intervention
Participants in this group will receive standard of care treatment.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
899 Previous Clinical Trials
409,732 Total Patients Enrolled
Raveen Syan, MDPrincipal InvestigatorUniversity of Miami

Media Library

SmileyScope VR Group Clinical Trial Eligibility Overview. Trial Name: NCT05928910 — N/A
Overactive Bladder Research Study Groups: SmileyScope VR Group, No VR Group
Overactive Bladder Clinical Trial 2023: SmileyScope VR Group Highlights & Side Effects. Trial Name: NCT05928910 — N/A
SmileyScope VR Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05928910 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experimental intervention accepting new participants?

"At present, this specific trial is not enrolling patients. It was first made available on September 30th 2023 and last edited on June 23rd 2023. However, there are currently 67 other studies in need of participants."

Answered by AI
~0 spots leftby Nov 2025